These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8826819)

  • 21. [Rapidly progressive visual disorder and cognitive impairment in a 66-year-old woman].
    Zarranz JJ; Berenguer J; Saiz A; Ribalta MT
    Med Clin (Barc); 2002 Jun; 119(4):149-57. PubMed ID: 12106528
    [No Abstract]   [Full Text] [Related]  

  • 22. Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease.
    Sanchez JC; Guillaume E; Lescuyer P; Allard L; Carrette O; Scherl A; Burgess J; Corthals GL; Burkhard PR; Hochstrasser DF
    Proteomics; 2004 Aug; 4(8):2229-33. PubMed ID: 15274116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.
    Aksamit AJ
    Arch Neurol; 2003 Jun; 60(6):803-4. PubMed ID: 12810481
    [No Abstract]   [Full Text] [Related]  

  • 24. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients.
    Kenney K; Brechtel C; Takahashi H; Kurohara K; Anderson P; Gibbs CJ
    Ann Neurol; 2000 Sep; 48(3):395-8. PubMed ID: 10976650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cerebrospinal fluid neuron-specific enolase as a useful indicator for the early diagnosis of Creutzfeldt-Jakob disease].
    Shibuya S; Wakayama Y; Jimi T
    Rinsho Shinkeigaku; 1997 Jul; 37(7):656; author reply 657. PubMed ID: 9396368
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
    Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
    Lemstra AW; van Meegen M; Baas F; van Gool WA
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
    Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
    Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
    Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
    Blennow K; Lind B; Andersson E; Andreasen N
    Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early and differential diagnosis of Creutzfeldt-Jakob disease].
    Zerr I; Mollenhauer B; Werner Ch; Poser S
    Dtsch Med Wochenschr; 2002 Feb; 127(7):323-7. PubMed ID: 11845388
    [No Abstract]   [Full Text] [Related]  

  • 33. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
    Donahue JE; Hanna PA; Hariharan S
    Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease.
    Will RG; Zeidler M; Brown P; Harrington M; Lee KH; Kenney KL
    Lancet; 1996 Oct; 348(9032):955. PubMed ID: 8843819
    [No Abstract]   [Full Text] [Related]  

  • 35. Atypical presentation of Creutzfeldt-Jakob disease: a rare but important cause of rapidly progressive dementia.
    Taillefer MS; Tangarorang GL; Kuchel GA; Menkes DL
    Conn Med; 2011 Sep; 75(8):473-8. PubMed ID: 21980678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H; Gatterbauer B; Radbauer C; Budka H
    Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
    Blennow K; Johansson A; Zetterberg H
    Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping.
    Piubelli C; Fiorini M; Zanusso G; Milli A; Fasoli E; Monaco S; Righetti PG
    Proteomics; 2006 Apr; 6 Suppl 1():S256-61. PubMed ID: 16511811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Cepek L; Brechlin P; Steinacker P; Mollenhauer B; Klingebiel E; Bibl M; Kretzschmar HA; Wiltfang J; Otto M
    Dement Geriatr Cogn Disord; 2007; 23(1):22-8. PubMed ID: 17068393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of Creutzfeldt-Jakob disease with markedly elevated ubiquitin concentration in the cerebrospinal fluid].
    Kurita K; Manaka H; Kato T; Katagiri T; Sasaki H
    Rinsho Shinkeigaku; 1991 Jun; 31(6):666-8. PubMed ID: 1657480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.